Breaking News Instant updates and real-time market news.

LK

Luckin Coffee

$39.84 /

+2.09 (+5.54%)

14:55
12/31/19
12/31
14:55
12/31/19
14:55

Luckin Coffee put volume heavy and directionally bearish

Bearish flow noted in Luckin Coffee with 67,428 puts trading, or 5x expected. Most active are 1/3 weekly 40 calls and Mar-20 20 puts, with total volume in those strikes near 8,100 contracts. The Put/Call Ratio is 1.93, while ATM IV is up nearly 6 points on the day. Earnings are expected on March 11th.

LK Luckin Coffee
$39.84 /

+2.09 (+5.54%)

11/29/19 Morgan Stanley
Luckin Coffee price target raised to $27 from $21 at Morgan Stanley
11/22/19 KeyBanc
Luckin Coffee price target raised to $32 from $24 at KeyBanc
06/12/19 CICC
Luckin Coffee initiated with a Buy at CICC
06/12/19 Citi
Citi survey shows little impact to Starbucks in China from trade war

TODAY'S FREE FLY STORIES

Downgrade
Trelleborg downgraded to Hold from Buy at Commerzbank » 05:19
10/28/20
10/28
05:19
10/28/20
05:19
TBABF

Trelleborg

$0.00 /

+ (+0.00%)

Commerzbank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Fiverr raises FY20 revenue view to $186M-$187M from $177.5M-$179.5M » 05:18
10/28/20
10/28
05:18
10/28/20
05:18
FVRR

Fiverr

$148.62 /

-5.735 (-3.72%)

Consensus $179.93M. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

08/27/20
MKM Partners starts Fiverr at Neutral, sees 'balanced' risk/reward
08/26/20 MKM Partners
Fiverr initiated with a Neutral at MKM Partners
08/10/20
Fly Intel: Top five analyst upgrades
08/10/20 Citi
Fiverr upgraded to Buy from Neutral at Citi
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

  • 29
    May
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

Downgrade
Veoneer downgraded to Underperform from Neutral at Credit Suisse » 05:18
10/28/20
10/28
05:18
10/28/20
05:18
VNE

Veoneer

$15.80 /

-0.38 (-2.35%)

Credit Suisse analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VNE Veoneer
$15.80 /

-0.38 (-2.35%)

VNE Veoneer
$15.80 /

-0.38 (-2.35%)

10/26/20 Kepler Cheuvreux
Veoneer downgraded to Reduce from Hold at Kepler Cheuvreux
10/22/20 Barclays
Veoneer price target raised to $17 from $10 at Barclays
10/19/20 Baird
Veoneer reinstated with a Neutral at Baird
10/16/20 Mizuho
Veoneer price target raised to $25 from $20 at Mizuho
VNE Veoneer
$15.80 /

-0.38 (-2.35%)

VNE Veoneer
$15.80 /

-0.38 (-2.35%)

Earnings
Fiverr sees Q4 revenue $52.4M-$53.4M, consensus $49.72M » 05:16
10/28/20
10/28
05:16
10/28/20
05:16
FVRR

Fiverr

$148.62 /

-5.735 (-3.72%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

08/27/20
MKM Partners starts Fiverr at Neutral, sees 'balanced' risk/reward
08/26/20 MKM Partners
Fiverr initiated with a Neutral at MKM Partners
08/10/20
Fly Intel: Top five analyst upgrades
08/10/20 Citi
Fiverr upgraded to Buy from Neutral at Citi
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

  • 29
    May
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

Downgrade
Aveva downgraded to Neutral from Outperform at Credit Suisse » 05:16
10/28/20
10/28
05:16
10/28/20
05:16
AVEVF

Aveva

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVEVF Aveva
$0.00 /

+ (+0.00%)

AVEVF Aveva
$0.00 /

+ (+0.00%)

10/13/20 Panmure Gordon
Aveva downgraded to Hold from Buy at Panmure Gordon
09/02/20 UBS
Aveva price target raised to 4,700 GBp from 3,785 GBp at UBS
09/01/20 UBS
Aveva price target raised to 4,700 GBp from 3,785 GBp at UBS
08/27/20 HSBC
Aveva upgraded to Hold from Reduce at HSBC
Downgrade
Virgin Money downgraded to Hold from Buy at Investec » 05:15
10/28/20
10/28
05:15
10/28/20
05:15
CYBBF

Virgin Money

$0.00 /

+ (+0.00%)

Investec analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYBBF Virgin Money
$0.00 /

+ (+0.00%)

10/12/20 Societe Generale
Virgin Money upgraded to Buy from Hold at Societe Generale
10/01/20 Investec
Virgin Money upgraded to Buy from Hold at Investec
08/18/20 Peel Hunt
Virgin Money initiated with a Buy at Peel Hunt
07/14/20 Deutsche Bank
Virgin Money resumed with a Buy at Deutsche Bank
Earnings
Fiverr reports Q3 EPS 13c, consensus 8c » 05:14
10/28/20
10/28
05:14
10/28/20
05:14
FVRR

Fiverr

$148.62 /

-5.735 (-3.72%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

08/27/20
MKM Partners starts Fiverr at Neutral, sees 'balanced' risk/reward
08/26/20 MKM Partners
Fiverr initiated with a Neutral at MKM Partners
08/10/20
Fly Intel: Top five analyst upgrades
08/10/20 Citi
Fiverr upgraded to Buy from Neutral at Citi
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

  • 29
    May
FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

FVRR Fiverr
$148.62 /

-5.735 (-3.72%)

Upgrade
Bechtle upgraded to Buy from Hold at Kepler Cheuvreux » 05:14
10/28/20
10/28
05:14
10/28/20
05:14
BECTY

Bechtle

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Capgemini upgraded to Buy from Neutral at Oddo BHF » 05:13
10/28/20
10/28
05:13
10/28/20
05:13
CGEMY

Capgemini

$0.00 /

+ (+0.00%)

Oddo BHF analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGEMY Capgemini
$0.00 /

+ (+0.00%)

10/20/20 HSBC
Capgemini upgraded to Buy from Hold at HSBC
10/08/20 Credit Suisse
Capgemini price target lowered to EUR 150 from EUR 160 at Credit Suisse
09/04/20 Societe Generale
Capgemini price target raised to EUR 152 from EUR 139 at Societe Generale
07/14/20 Credit Suisse
Capgemini price target raised to EUR 150 from EUR 130 at Credit Suisse
Hot Stocks
Aerie, Santen enter exclusive agreement for Rhopressa and Rocklatan in Japan » 05:12
10/28/20
10/28
05:12
10/28/20
05:12
AERI

Aerie Pharmaceuticals

$9.94 /

+0.17 (+1.74%)

Santen Pharmaceutical and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$9.94 /

+0.17 (+1.74%)

AERI Aerie Pharmaceuticals
$9.94 /

+0.17 (+1.74%)

10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
09/08/20
Fly Intel: Top five analyst initiations
09/08/20 Guggenheim
Aerie Pharmaceuticals initiated with a Buy at Guggenheim
AERI Aerie Pharmaceuticals
$9.94 /

+0.17 (+1.74%)

AERI Aerie Pharmaceuticals
$9.94 /

+0.17 (+1.74%)

Recommendations
Piper Sandler says buy DexCom despite disappointing G7 update » 05:11
10/28/20
10/28
05:11
10/28/20
05:11
DXCM

DexCom

$380.38 /

-37.52 (-8.98%)

DexCom's Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$380.38 /

-37.52 (-8.98%)

DXCM DexCom
$380.38 /

-37.52 (-8.98%)

10/27/20 Canaccord
DexCom weakness a buying opportunity, says Canaccord
10/27/20 Baird
DexCom weakness a buying opportunity, says Baird
10/26/20 Piper Sandler
DexCom's Q3 pre-announcement impacted by tough comp, says Piper Sandler
10/16/20 Citi
Citi opens 'positive catalyst watch' on DexCom
DXCM DexCom
$380.38 /

-37.52 (-8.98%)

DXCM DexCom
$380.38 /

-37.52 (-8.98%)

DXCM DexCom
$380.38 /

-37.52 (-8.98%)

General news
FX Action: The yen has been on the ascent » 05:10
10/28/20
10/28
05:10
10/28/20
05:10

FX Action: The yen has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Fiat Chrysler, Peugeot announce Stellantis combination update » 05:08
10/28/20
10/28
05:08
10/28/20
05:08
FCAU

Fiat Chrysler

$12.91 /

-0.355 (-2.68%)

, PUGOY

Peugeot

$0.00 /

+ (+0.00%)

Fiat Chrysler (FCAU) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FCAU Fiat Chrysler
$12.91 /

-0.355 (-2.68%)

PUGOY Peugeot
$0.00 /

+ (+0.00%)

FCAU Fiat Chrysler
$12.91 /

-0.355 (-2.68%)

10/15/20 UBS
Fiat Chrysler price target raised to EUR 10.50 from EUR 9 at UBS
09/08/20 Bernstein
Fiat Chrysler initiated with an Underperform at Bernstein
08/04/20 Jefferies
Ford, FCA price targets raised at Jefferies following earnings
06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
PUGOY Peugeot
$0.00 /

+ (+0.00%)

09/08/20 Bernstein
Peugeot initiated with an Underperform at Bernstein
07/30/20 RBC Capital
Peugeot price target raised to EUR 14 from EUR 13 at RBC Capital
06/30/20 UBS
Peugeot upgraded to Buy from Neutral at UBS
06/22/20 Redburn
Peugeot upgraded to Buy from Neutral at Redburn
FCAU Fiat Chrysler
$12.91 /

-0.355 (-2.68%)

FCAU Fiat Chrysler
$12.91 /

-0.355 (-2.68%)

PUGOY Peugeot
$0.00 /

+ (+0.00%)

FCAU Fiat Chrysler
$12.91 /

-0.355 (-2.68%)

FCAU Fiat Chrysler
$12.91 /

-0.355 (-2.68%)

Recommendations
Masimo price target raised to $280 from $250 at Piper Sandler » 05:06
10/28/20
10/28
05:06
10/28/20
05:06
MASI

Masimo

$251.18 /

+5.3 (+2.16%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MASI Masimo
$251.18 /

+5.3 (+2.16%)

MASI Masimo
$251.18 /

+5.3 (+2.16%)

10/06/20 Piper Sandler
Better than expected sensor utilization drove Masimo upside, says Piper Sandler
09/01/20 Baird
Masimo initiated with an Outperform at Baird
08/14/20
Fly Intel: Top five analyst initiations
08/14/20 Piper Sandler
Masimo assumed with an Overweight at Piper Sandler
MASI Masimo
$251.18 /

+5.3 (+2.16%)

MASI Masimo
$251.18 /

+5.3 (+2.16%)

Recommendations
Omnicell price target raised to $86 from $70 at Piper Sandler » 05:04
10/28/20
10/28
05:04
10/28/20
05:04
OMCL

Omnicell

$85.68 /

+1.75 (+2.09%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMCL Omnicell
$85.68 /

+1.75 (+2.09%)

OMCL Omnicell
$85.68 /

+1.75 (+2.09%)

07/29/20 Craig-Hallum
Omnicell price target lowered to $85 from $102 at Craig-Hallum
07/29/20 Cantor Fitzgerald
Omnicell price target raised to $90 from $85 at Cantor Fitzgerald
07/29/20 Piper Sandler
Omnicell price target lowered to $70 from $76 at Piper Sandler
07/06/20 Stephens
Omnicell initiated with an Overweight at Stephens
OMCL Omnicell
$85.68 /

+1.75 (+2.09%)

Downgrade
Livongo Health downgraded to Neutral from Overweight at Piper Sandler » 05:02
10/28/20
10/28
05:02
10/28/20
05:02
LVGO

Livongo Health

$143.00 /

+6.29 (+4.60%)

, TDOC

Teladoc

$222.62 /

+10.365 (+4.88%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

05:00 Today Piper Sandler
Teladoc price target raised to $305 from $232 at Piper Sandler
10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
08/25/20 Guggenheim
Teladoc, Livongo merger strengthens both businesses, says Guggenheim
TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

05:00 Today Piper Sandler
Teladoc price target raised to $305 from $232 at Piper Sandler
10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
09/22/20
Top five analyst initiations
LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

  • 12
    Dec
TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

Recommendations
Teladoc price target raised to $305 from $232 at Piper Sandler » 05:00
10/28/20
10/28
05:00
10/28/20
05:00
TDOC

Teladoc

$222.62 /

+10.365 (+4.88%)

, LVGO

Livongo Health

$143.00 /

+6.29 (+4.60%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
09/22/20
Top five analyst initiations
09/22/20 DA Davidson
Teladoc initiated with a Buy at DA Davidson
LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
08/25/20 Guggenheim
Teladoc, Livongo merger strengthens both businesses, says Guggenheim
08/24/20 Stifel
Livongo Health downgraded to Hold from Buy at Stifel
TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

  • 12
    Dec
TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

TDOC Teladoc
$222.62 /

+10.365 (+4.88%)

LVGO Livongo Health
$143.00 /

+6.29 (+4.60%)

Downgrade
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs » 04:57
10/28/20
10/28
04:57
10/28/20
04:57
RLMD

Relmada Therapeutics

$33.13 /

+0.09 (+0.27%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLMD Relmada Therapeutics
$33.13 /

+0.09 (+0.27%)

RLMD Relmada Therapeutics
$33.13 /

+0.09 (+0.27%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
05/27/20 Goldman Sachs
Goldman says Relmada clearance for Phase 3 supports REL-1017 safety, efficacy
05/04/20 SunTrust
Relmada Therapeutics initiated with a Buy at SunTrust
05/04/20
Fly Intel: Top five analyst initiations
  • 04
    Dec
Conference/Events
UBS Asia tech analysts to hold analyst/industry conference call » 04:55
10/28/20
10/28
04:55
10/28/20
04:55

Asia Technology Analyst…

Asia Technology Analyst Research Team, along with the Senior Manager at Casetek, discuss the iPhone casing production process from the 2D/3D design blueprints for the cases to actual manufacturing, materials used for cases for different brands, anodic oxidation, etc., on an Analyst/Industry conference call to be held on October 28 at 10 pm.

Conference/Events
Cantor Fitzgerald healthcare analyst to hold analyst/industry conference call » 04:55
10/28/20
10/28
04:55
10/28/20
04:55
KHRNF

Khiron Life Sciences

$0.00 /

+ (+0.00%)

, PCLOF

Pharmacielo

$0.00 /

+ (+0.00%)

Healthcare Analyst Zuanic…

Healthcare Analyst Zuanic discusses the LatAm Cannabis Industry with David Attard, CEO Pharmacielo and Alvaro Torres, CEO of Khiron, on an Analyst/Industry conference call to be held on October 28 at 10 am.

ShowHide Related Items >><<
KHRNF Khiron Life Sciences
$0.00 /

+ (+0.00%)

KHRNF Khiron Life Sciences
$0.00 /

+ (+0.00%)

PCLOF Pharmacielo
$0.00 /

+ (+0.00%)

07/22/20 Stifel
Pharmacielo re-initiated with a Speculative Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
KHRNF Khiron Life Sciences
$0.00 /

+ (+0.00%)

Conference/Events
Umpqua Holdings management to meet virtually with Truist » 04:55
10/28/20
10/28
04:55
10/28/20
04:55
UMPQ

Umpqua Holdings

$12.52 /

-0.83 (-6.22%)

Virtual Meetings to be…

Virtual Meetings to be held on October 27-28 hosted by Truist.

ShowHide Related Items >><<
UMPQ Umpqua Holdings
$12.52 /

-0.83 (-6.22%)

10/27/20
Fly Intel: Top five analyst downgrades
10/27/20 JPMorgan
JPMorgan cuts Umpqua to Underweight, sees 'tinder box for downgrades'
10/27/20 Stephens
Umpqua Holdings resumed with an Overweight at Stephens
10/27/20 JPMorgan
Umpqua Holdings downgraded to Underweight from Neutral at JPMorgan
UMPQ Umpqua Holdings
$12.52 /

-0.83 (-6.22%)

Conference/Events
VYNE Therapeutics management to meet virtually with Cantor Fitzgerald » 04:55
10/28/20
10/28
04:55
10/28/20
04:55
VYNE

VYNE Therapeutics

$1.80 /

-0.02 (-1.10%)

Virtual Meetings to be…

Virtual Meetings to be held October 28-29 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
VYNE VYNE Therapeutics
$1.80 /

-0.02 (-1.10%)

VYNE VYNE Therapeutics
$1.80 /

-0.02 (-1.10%)

10/05/20 H.C. Wainwright
VYNE Therapeutics price target raised to $3.50 from $3 at H.C. Wainwright
VYNE VYNE Therapeutics
$1.80 /

-0.02 (-1.10%)

Conference/Events
Morgan Stanley oil/gas and E&P analysts hold analyst/industry conference call » 04:55
10/28/20
10/28
04:55
10/28/20
04:55

Canadian Oil & Gas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Cowen financial services analyst to hold analyst/industry conference call » 04:55
10/28/20
10/28
04:55
10/28/20
04:55
NOVS

Novus Capital Corp.

$11.60 /

+0.2 (+1.75%)

Analyst Osborne &…

Analyst Osborne & Bollman provide an update on AppHarvest ahead of the proposed merger with Novus Capital Corporation on an Analyst/Industry conference call to be held on October 28 at 2 pm.

ShowHide Related Items >><<
NOVS Novus Capital Corp.
$11.60 /

+0.2 (+1.75%)

NOVS Novus Capital Corp.
$11.60 /

+0.2 (+1.75%)

General news
Week of 10/23 MBA Mortgage Applications to be released at 07:00  04:55
10/28/20
10/28
04:55
10/28/20
04:55
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.